Galli® Technology

Galli® is Theragnostics’ proprietary platform for the development of single-step kits for the preparation of gallium-containing pharmaceuticals. Our vision is for cancer patients to realise the benefits of new imaging and therapeutic agents far more rapidly than is possible today, through the simplification enabled by Galli®.
Galli® simplifies the infrastructure required to deliver radiolabelled compounds to the clinic, drawing parallels with “shake and shoot” kits that brought technetium into the nuclear medicine mainstream.

GalliTM Technology one-step kits for 68Ga labelling